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Abbreviations: FSGS (focal segmental glomerulosclerosis) ESRF (end stage renal failure)  
INF2 (inverted formin 2) DAD (diaphanous activation domain) DID (diaphanous inhibitory 
domain) FH1 and 2 domain (formin homology1 and 2) WH2 domain (Wiskott-Aldrich 
syndrome homology region 2) 
 
Summary Statement: Mutations in INF2 cause Focal Segmental Glomerulosclerosis a major 
cause of end-stage kidney disease. Here we show that disease associated mutations reduce 
INF2 auto-inhibition and cause increased binding to monomeric G-actin, profilin 2 and the F-
actin capping protein, CapZ alpha-1. 
 
Key Words: FSGS, podocytes, actin cytoskeleton, proteomics. 
 
Short Title:  Disease causing mutations in Inverted Formin 2 regulate its function. 
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Abstract 
 
Focal segmental glomerulosclerosis (FSGS) is a devastating form of nephrotic syndrome 
which ultimately leads to end stage renal failure (ESRF). Mutations in INF2, a member of the 
formin family of actin-regulating proteins, have recently been associated with a familial 
cause of nephrotic syndrome characterised by FSGS. INF2 is a unique formin that can both 
polymerize and depolymerize actin filaments. How mutations in INF2 lead to disease is 
unknown. Here we show that 3 mutations associated with FSGS, E184K, S186P and R218Q, 
reduce INF2 auto-inhibition and increase association with monomeric actin. Furthermore 
using a combination of GFP-INF2 expression in human podocytes and GFP-Trap purification 
coupled with Mass Spectrometry we demonstrate that INF2 interacts with profilin 2 and the 
F-actin capping protein, CapZ alpha-1. These interactions are increased by the presence of 
the disease causing mutations. Since both these proteins are involved in the dynamic turnover 
and restructuring of the actin cytoskeleton these changes strengthen the evidence that aberrant 
regulation of actin dynamics underlies the pathogenesis of disease.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ac
ce
pte
d M
an
us
cri
pt
© 2016 The Author(s) Archiving permitted only in line with the archiving policy of Portland Press Limited.
The final version of record will be available under the Creative Commons Attribution Licence 3.0
(http://creativecommons.org/licenses/by/3.0/). You are encouraged to use the final version of record.
Introduction 
The glomerulus is the filtration unit of the kidney and is composed of a bundle of 
capillaries which are highly permeable to water, and yet are able to selectively allow passage 
of solutes while retaining larger macromolecules. This selectivity is achieved through the 
action of the glomerular filtration barrier which consists of the glomerular endothelial cells, 
glomerular basement membrane, and podocytes. Podocytes are terminally differentiated 
epithelial cells that are critical in preventing protein passage across the filtration barrier. 
Podocytes have branching and interdigitating processes, and filtration takes place through 
slits between these processes. The maintenance of its specific cell morphology is essential for 
the proper functioning of podocytes and this is largely dependent on a highly dynamic 
underlying network of protein scaffolding. The shape of this cytoskeleton is dictated by a 
number of regulatory factors, and disruption of function can lead to a failure to form an 
appropriate cell shape, which in turn can lead to a disease state [1].  Focal and segmental 
glomerulosclerosis (FSGS) is a major cause of end-stage kidney disease. Recent advances in 
molecular genetics show that defects in the podocyte play a major role in the pathogenesis of 
FSGS [2-4] and that mutations in inverted formin 2 (INF2), a member of the formin family of 
actin-regulating proteins, cause autosomal dominant FSGS [5-7].  
INF2 is a member of the Diaphanous sub family of formins and has a similar domain 
architecture to other related subfamily members.  The N-terminal half comprises a 
predominantly regulatory function and encompasses an overlapping Rho binding domain and 
Diaphanous Inhibitory Domain (DID).  The C-terminal half includes Formin Homology 
Domains 1 and 2 (FH1 and FH2) and a Diaphanous Autoregulatory Domain (DAD).  The 
DAD domain also acts as a monomeric G-actin binding WH2 domain.   
INF2 is unique among the formin family members in that it possesses a dual catalytic 
activity with regard to actin dynamics.  As well as nucleating actin filaments and promoting 
their elongation, INF2 can also accelerate F-actin depolymerisation and filament severing [8].  
This severing and depolymerisation activity appears to be dependent on the activity of both 
the FH2 and WH2 domains acting in concert [9]. Regulation of other members of the 
diaphanous related subfamily of formins is achieved through interaction of the DID and DAD 
domains, constraining the formin in a closed conformation which inhibits its actin nucleating 
and polymerising activities.  This auto-inhibition is at least partially relieved through binding 
of active, GTP-bound Rho GTPases to the N-terminal DID domain. Unusually, in the case of 
INF2, DID-DAD interaction does not inhibit actin polymerisation but does inhibit actin 
depolymerisation and severing [9].   
In T-lymphocytes INF2 regulates MAL-mediated transport of the src-family kinase 
lymphocyte-specific protein tyrosine kinase Lck to the plasma membrane [10]. INF2 
functions in the regulation of basolateral-to-apical transcytosis and lumen formation, 
perinuclear actin assembly and in an actin dependent step in mitochondrial fission [11-13]. In 
cultured podocytes INF2 has been reported to regulate cellular actin dynamics by 
antagonizing Rho/diaphanous –related formin signalling and disease causing mutations have 
been shown to alter this signalling in the glomerulus [14, 15]. INF2 has been shown to bind 
to and be regulated by the Rho-GTPase CDC42 in a GTP-loaded-dependent manner via its 
DID domain although there is a question as to whether this is a direct interaction [11, 16, 
17].The mutant forms of INF2 show increased binding to cdc42.  
We studied three disease causing mutations in INF2 (E184K, S186P and R218Q) that 
all lie within the diaphanous inhibitory domain.  We show that these mutations reduce INF2 
auto-inhibition by weakening the interaction between the DID and DAD domains leading to 
an increased association with monomeric actin. Further we demonstrate an interaction of 
INF2 with profilin 2 and the F-actin capping protein, CapZ alpha-1 both of which are 
increased by the presence of the disease causing mutations.  
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Material and Methods 
 
Material and Methods 
 
Co Immuoprecipitation and pulldowns 
pET32a-INF2-DAD was made by PCR cloning using 2850 to 3750 of the coding region of 
INF2. The construct was also FLAG tagged at the N- terminus. The pGEX4T3-INF2-DID-
WT, -E184K, -R218Q and -S186P constructs were made by PCR using 4 to 1029 of the INF2 
coding region and the constructs were HA tagged at the C-terminus. All constructs were 
transformed into Rosetta cells (Novagen) for protein expression. Constructs were grown in 
100ml (HIS tagged portiens) or 50ml (HA tagged proteins) of LB and protein expression 
induced with 100mM IPTG, pelleted and resuspended in 5ml lysis buffer (PBS, 1% Triton 
TX-100, 1mM PMSF, protease inhibitor cocktail (Sigma), 10mM Imidazole). Cells were 
lysed by sonication, pelleted and the HIS tagged protein supernatants were incubated with 
HisPur Cobalt resin (Pierce) with 2% BSA for 30 minutes at 4
0
C. Beads were washed x5 with 
lysis buffer (plus an extra 100mM NaCl), resuspended and snap frozen in liquid N2, each 
aliquot having 10 – 20g of protein linked to the beads.  Aliquots of agarose bead linked 
INF2-DAD and control were incubated with HA tagged DID domain lysates for 1 hour at 
4
0
C, beads were then washed x5 with wash buffer (PBS + extra 100mM NaCl, 1mM PMSF), 
boiled for 10 minutes with sample buffer, separated by PAGE, transferred to PVDF and 
probed with an anti HA antibody.  
For co immunoprecipitation of endogenous protein 5mg of polyclonal INF2 antibody or 
Rabbit Ig (Bethyl Labs or Millipore) was incubated with protein A/G agarose beads 
overnight, the beads were washed and incubated with lysates from differentiated podocytes 
(10mM Tris pH 7.5, 150mM NaCl, 0.5mM EDTA, 2% NP40, 10% Glycerol, protease 
inhibitor cocktail (Sigma), 1mM PMSF) for 1 hour at 4
0
C. The beads were washed x5 
(10mM Tris pH 7.5, 150mM NaCl, 0.5mM EDTA, protease inhibitor cocktail, 1mM PMSF), 
eluted, boiled, separated and blots were probed with relevant antibodies.  
For co immunoprecipitation of over expressed protein HEK 293-T cells were transfected with 
GFP-INF2-WT, -E184K, -R218Q or -S186P and cotransfected with HACdc42QL (A gift 
from Harry Mellor) or a transfection control plasmid. After 48 hours cells were lysed in 
buffer (10mM Tris pH 7.5, 150mM NaCl, 0.5mM EDTA, 2% NP40, 10% Glycerol, protease 
inhibitor cocktail (Sigma), 1mM PMSF), pelleted and the supernatant incubated with GFP 
Trap agarose beads (Chromotek). After rotating at 4
0
C for 1 hour the beads were washed x5 
(10mM Tris pH 7.5, 150mM NaCl, 0.5mM EDTA, protease inhibitor cocktail, 1mM PMSF), 
protein was eluted in 50l sample buffer, separated, transferred and blots were probed with 
relevant antibodies. 
For Co-IP of G-actin, HEK293T cells were seeded into a 6-well plate and transfected with 
FLAG-INF2-WT, -E184K, -R218Q, -S186P or transfection control. After expression, cells 
were lysed in 100µl lysis buffer (50mM Tris, pH7.5, 120mM NaCl, 1% NP40, 40mM β-
glycerophosphate, 1mM benzamidine) and incubated on ice for 60mins to allow complete F-
actin depolarization. INF2 was immunoprecipitated with anti-FLAG M2 (Sigma) and protein 
G magnetic beads (pre-blocked with 1% BSA) for 6 hours at 4C.  IP’s were washed 3 times 
with 500ml wash buffer (50mM Tris, pH7.5, 120mM NaCl, 0.5% NP40, 10% glycerol) and 
protein eluted by boiling with SDS sample buffer.  Protein was resolved by SDS PAGE and 
probed by western blot for INF2 (via FLAG-tag) and actin. 
 
Proteomics 
GFP-INF2-WT was subcloned into pWPXL  (pWPXL was a gift from Didier Trono 
(Addgene plasmid # 12257)) and together with packaging vectors pMDG.2 and psAX2 
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(pMD2.G was a gift from Didier Trono (Addgene plasmid # 12259) and psPAX2 was a gift 
from Didier Trono (Addgene plasmid # 12260)) transfected into Lenti-X 293T Cell Line 
(Clontech). Human podocytes were transduced with GFP or GFP-INF2 lentivirus with 
8µg/ml polybrene overnight, the cells were thermo switched and differentiated for a 
minimum of 10 days [18]. 2x 175 tissue culture flasks were lysed and GFP and GFP-INF2 
protein and interacting proteins were immuprecipitated using the GFP-TRAP system 
(Chromotek). Samples were separated on Nupage 4–12% precast gels (Invitrogen) and 
subjected to LC-MS/MS analysis on an Orbitrap Velos (Thermo) mass spectrometer as 
described previously [19, 20] 
 
Immunofluorescence 
Conditionally immortalised Human podocytes stabley expressing GFP-INF2 were seeded 
onto coverslips in a six well plate or onto imaging dishes (MatTek) and differentiated for a 
minimum of 10 days. Cells were fixed in 4% PFA and permabilised wtih 0.3% Triton TX-
100 in PBS for 5 minutes. After blocking in 3% BSA cells were incubated in the relevant 
primary and secondary antibodies and mounted on slides in vectashield with DAPI (Vector 
Labs). Images were captured using a Leica AM TIRF MC (multi-colour) system attached to a 
Leica DMI 6000 inverted epifluorescence microscope equipped with 405, 488, 561nm, 
635nm laser lines. 
 
Antibodies and other reagents 
Mouse monoclonals: anti HA (Covance), GFP (Roche) FLAG (Sigma), Rabbit polyclonals: 
anti F-Actin capping protein (Millipore), Profilin2 (Sigma), Tubulin (Sigma), INF2 (Bethyl 
Labs, Millipore). Phalloidin-647 (Molecular Probes).  
 
 
Results 
 
INF2 has been reported to localize to the endoplasmic reticulum (ER) [9]. In conditionally 
immortalized human podocytes we used total internal reflection fluorescence microscopy 
(TIRF) to study the localization of INF2 near the plasma membrane and to exclude the ER 
pool. This demonstrated that there is INF2 at the cell periphery which colocalises with both 
tubulin and actin (Figure 1A). Using Flag tagged wild type and three disease causing 
mutations in INF2 (E184K, S186P and R218Q) that all lie within the diaphanous inhibitory 
domain (Figure 2A) we show that INF2 interacts with actin and this interaction is increased 
in the presence of the disease causing mutations (Figure 1B and C).  Actin has been shown to 
bind to the WH2 domain of INF2 which also acts as a diaphanous auto-regulatory domain 
(DAD) binding to the diaphanous inhibitory domain (DID) to auto-regulate INF2 activity [9]. 
Therefore to determine if this increase in actin binding was due to a loss of DID:DAD 
interaction we expressed  and purified His tagged INF2-DAD, linked the fusion protein to 
Co2+ beads and used these to pulldown HA tagged INF2-DID-WT, -E184K, -R218Q and -
S186P to measure the relative binding capacity of the wild type and mutant DID domains 
with the DAD domain. Only the wild type DID interacted with DAD.  This demonstrated that 
in the disease causing mutations the DID:DAD interaction is disrupted (Figure 2B,C) and 
therefore the FH2 domain becomes accessible thus leading to the increased association with 
monomeric actin.  
In order to further explore the effect of these mutations on INF2 biology we expressed GFP 
tagged INF2 in podocytes using lentiviral transduction. GFP-INF2 co localises with F-actin 
as expected in differentiated podocytes so we were confident that the fusion protein is 
properly localised (Figure 3A). These and control cells, expressing GFP only, were then lysed 
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and the GFP immunoprecipitated using the highly efficient GFP-trap method [21]. The 
precipitated GFP and GFP-INF2 were separated by SDS-PAGE and interacting proteins 
analysed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) after in-gel 
tryptic digestion. The mass spectrometry analysis identified two proteins, profilin 2 and F-
actin capping protein (CapZ alpha-1), that were significantly more abundant in the GFP-INF2 
pulldown compared to the GFP control (Figure 3B, C). To confirm the mass spectrometry 
results further pull downs were undertaken using both overexpressed and endogenous INF2 
in podocytes showing that indeed INF2 interacts with both proteins (Figure 4B, C).  
Furthermore TIRF microscopy in human podocytes showed colocalization of INF2 with F-
actin capping protein at the periphery of the cell (Figure 4A). We used F-actin capping 
protein and profilin pull down as a readout for INF2 activity as it has been previously 
reported that profilin binds to the FH1 domain of mDia [22] and we speculated that the loss 
of interaction between the DAD and mutant form of DID will lead to activated INF2 and 
therefore increased interaction with target proteins. This proved to be the case as the mutant 
forms of INF2 pulled down significantly more F-actin capping protein and profilin than the 
wild type. (Figure 5A, B, C).  
INF2 is reported to bind to the Rho-GTPase CDC42 and the mutant forms of INF2 are 
reported to show increased binding to this protein [11, 16, 17]. We co-expressed GFP-INF2 
with the active form of cdc42 (cdc42QL [23]) and demonstrated that there was an interaction 
(Figure 5D). Furthermore we showed that the presence of the active cdc42 resulted in a 
significant increase in the interaction between wild type INF2 and the F-actin capping protein 
(Figure 5E). 
 
 
 
Discussion 
 
Focal segmental glomerulosclerosis (FSGS) is a devastating form of nephrotic 
syndrome. The aetiology of FSGS is still unknown although inherited forms of the disease 
are now providing revolutionary clues to the underlying pathogenesis and target the 
glomerular podocyte [4, 24]. Podocytes are the final layer in the kidney's glomerular capillary 
wall. Together with the basement membrane and glomerular endothelial cells they form the 
barrier through which filtration occurs. Podocytes play an essential role in preventing 
proteinuria and are an important target in the pathogenesis of renal disease. Podocytes have a 
remarkably elaborate and highly specialised morphology that is dependent on the actin 
cytoskeleton and which is essential for maintaining glomerular function and integrity in 
healthy kidneys [1].  There is compelling evidence that podocytes display a limited 
physiological motility, and that changes in podocyte motility may underlie nephrotic disease 
[1, 25]. Thus it is clear that the specialized function of the podocyte in the normal kidney 
depends critically on an underlying network of dynamic and interconnected actin and 
microtubule polymers. The mechanism through which this morphology is achieved and 
maintained in the normal kidney is not currently understood.  
Mutations in the DID domain of the formin family member, INF2, have recently been 
associated with focal segmental glomerulosclerosis (FSGS) [3-7] and in Charcot-Marie-
Tooth disease with glomerulopathy [16]. Formins are a highly conserved family of large 
multi-domain proteins that play essential roles in the regulation of actin and microtubule 
cytoskeletons [26].  Interestingly certain of these mutations only result in a renal phenotype 
suggesting that these cause a disruption of podocyte morphology as a result of aberrant 
regulation of actin dynamics [16].  Little is known about the role of the INF2 DID domain, 
although one study has shown that association of INF2 DID domain with the DAD domain of 
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the related family member, mDia1 inhibited RhoA-mDia dependent actin polymerisation and 
serum response factor regulated gene transcription [14].  
We have shown that recombinant, truncated INF2 regions comprising the DID and 
DAD domains interact in vitro and that FSGS associated mutations (E184K, S186P and 
R218Q) reduce the affinity of this interaction.  The mutant forms of INF2 also show an 
increased association with monomeric actin as shown by co-immunoprecipitation. This 
would be consistent with the auto-regulation of other formins whereby interaction of the DID 
and DAD domains constrains INF2 in a closed conformation inhibiting its actin nucleating 
and polymerising activities. Loss of this auto-inhibition through loss of affinity of the DID 
and DAD interaction leads to revealing of the WH2 domain and increased actin binding. This 
is in agreement with previous data showing that disruption of the DID/DAD interaction 
causes constitutive actin polymerization by INF2 in cells [17]. 
Using a combination of GFP-INF2 expression in human podocytes and GFP-Trap 
purification coupled with Mass Spectrometry we identified profilin 2 and the F-actin capping 
protein, CapZ alpha-1 as interactors of INF2. These interactions were confirmed using both 
expressed and endogenous INF2. Importantly these interactions are increased by the presence 
of the disease causing mutations and by the co-expression of an active CDC42 construct. 
CDC42 is a known regulator of INF2 so this data suggests that both the mutations and cdc42 
lead to a decrease in the DID/DAD interaction increasing the binding of actin, profilin 2 and 
the F-actin capping protein [11].   
Profilin is a known interactor of the formin family and has been shown to regulate the 
effects of these proteins on actin dynamics [27-29]. Indeed profilin has recently been shown 
in fission yeast cells to regulate the F-actin network by favouring formin over the Arp2/3 
complex [30]. INF2 and profilin have been shown to regulate the assembly and turnover of 
short actin filaments [31]. Therefore the increased binding of profilin to INF2 in the presence 
of the disease causing mutations is likely to have a significant effect on the regulation of 
podocyte actin dynamics. Furthermore we have demonstrated that INF2 also binds to CapZ 
alpha 1 and that like profilin this binding is also increased in the presence of the disease 
causing mutations. Actin capping proteins are key regulators of actin dynamics and formins 
have been shown to antagonize the actions of these proteins [32, 33]. Interestingly, in fission 
yeast during cytokinesis profilin has been shown to mediate the competition between capping 
protein and formin [34]. Therefore this again suggests that the FSGS causing mutations will 
disrupt the tight regulation of the podocyte actin cytoskeleton. 
Apart from its role in the regulation of actin dynamics INF2, like other formins, has 
been shown to bind and have effects on microtubules [35] and is thought that formins may act 
to co-ordinate actin filaments and microtubules which is essential for many cellular processes 
[26, 36]. In cultured podocytes INF2 regulates cellular actin dynamics by antagonizing 
Rho/diaphanous –related formin signalling and disease causing mutations have been shown 
to this alter this signalling in the glomerulus [14, 15]. mDia mediates Rho-regulated 
formation and orientation of stable microtubules and actin-capping protein promotes 
microtubule stability by antagonizing the actin activity of mDia [37, 38]. Therefore this 
suggests that actin capping protein may function by co-ordinating cross-talk between actin 
and microtubules and this may be disrupted by the disease causing INF2 mutations.  In 
support of this INF2 has been shown to organizes lumen and cell outgrowth during 
tubulogenesis by regulating both F-actin and microtubule cytoskeletons and the authors of 
this paper suggested that the effects of disease causing INF2 mutations may be via alternative 
or additional mechanisms to altered actin regulation namely via effects on microtubular 
dynamics[39].  
 Capz has been shown to interact with CD2AP which plays a key role in the 
maintenance of the podocyte slit diaphragm [40] and INF2 has been shown to bind to nephrin 
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and to regulate lipid raft–mediated lamellipodial trafficking of slit diaphragm proteins [14]. 
Interestingly CD2AP was identified as a binding partner of INF2 in our proteomic screen 
although this is still to be confirmed (Figure 3). Nephrin and the slit diaphragm complex are 
known to be a crucial regulators of the podocyte cytoskeleton and therefore our data suggests 
that INF2 binding to profilin and Capz alpha 1 may play a critical role in the tight regulation 
of podcoyte actin and microtubular dynamics via interaction with the podocyte slit diaphragm 
and this is altered in the presence of disease causing mutations [1]. 
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Figure 5 
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Figure Legends 
Figure 1 
A. Cellular localisation of INF2 in differentiated conditionally immortalised Human podocytes. B. 
Representative western blot of a co IP between G-actin and FLAG tagged wild type and mutant INF2. C. Graph 
of relative interactions between G-actin and the wild type and mutant INF2. n = 6, significance * P≤0.05 
 
Figure 2 
A. Schematic representation of INF2 showing the Diaphanous Interacting Domain and the position of the 
E184K, R218Q and S186P mutants, the FH1 and FH2 domains and the Diaphanous Autoinhibitory Domain. B. 
Representative western blot of a pulldown experiment between HIS:Diaphanous Autoinhibitory Domain 
immobilised on Co
2+
 agarose beads and wild type and mutant HA linked DID domains. C. Graph of relative 
interactions between the INF2 DAD and the wild type and mutant DID. n = ≥ 4, significance * P≤0.05 
 
Figure 3 
A. TIRF images of Co localisation between GFP-INF2 and F-actin in differentiated ciPodocytes. B.  Western 
blot of an IP using GFP-TRAP in differentiated ciPodocytes and probed with an anti GFP antibody. C. Selected 
proteins identified by Mass spec that interact with GFP-INF2 in differentiated ciPodocytes. 
 
 
Figure 4 
A. TIRF images of colocalisation between GFP-INF2WT and F-Actin capping protein in ciPodocytes. B. 
Western blots of IPs using GFP-TRAP in differentiated podocytes probed with an F-Actin capping protein 
antibody and a Profilin-2 antibody. C. Western Blot of a co IP of endogenous protein using an INF2 antibody 
linked to agarose beads and probed with antibodies to INF2,  F-Actin Capping Protein and Profilin-2.  
 
 
Figure 5 
A. Representative western blots of the co IP of Profilin-2 and either GFP-INF2WT, GFP-INF2E184K, GFP-
INF2R218Q or GFP-INF2S186P. B. Representative western blots of the co IP of F-actin capping protein and 
either GFP-INF2WT, GFP-INF2E184K, GFP-INF2R218Q or GFP-INF2S186P.  C. Graphical representation of 
the relative amount F-actin capping protein and profilin-2 that co IPs with GFP-INF2WT, GFP-INF2E184K, 
GFP-INF2R218Q or GFP-INF2S186P normalised for expression levels and relative to GFP-INF2WT which is 
set at 1. n=≤3. D. Western blot of a co IP of GFP-INF2WT and HA-Cdc42QL. E. Representative western blot of 
the co IP of F-Actin capping protein co transfected with control or HACdc42QL. F. Graph of the relative 
amount of F-actin capping protein that co-IPs with GFP-INF2WT + control and GFP-INF2WT + HACdc42QL 
normalised to GFP-INF2WT+Control which is set at 1. n≥4, significance * P≤0.05, ** P≤0.01 
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